Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
Alpha2-antiplasmin (α2AP), the fast-reacting, serine protease inhibitor (serpin) of plasmin, was originally thought to play a key role in protection against uncontrolled, plasmin-mediated proteolysis of coagulation factors and other molecules. However, studies of humans and mice with genetic deficie...
Main Authors: | Satish Singh, Sofiyan Saleem, Guy L. Reed |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.608899/full |
Similar Items
-
Alpha 2-antiplasmin deficiency in a Sudanese child: a case report
by: Bashir Abdrhman Bashir Mohammed
Published: (2021-05-01) -
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization
by: Gustavo Cernera, et al.
Published: (2020-04-01) -
Relation of a<sub>2</sub>-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
by: Berthold Hoppe, et al.
Published: (2020-12-01) -
Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
by: Michał Ząbczyk, et al.
Published: (2020-03-01) -
Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous Thromboembolism
by: Samuel Francis, et al.
Published: (2019-01-01)